1. Home
  2. IT vs MDGL Comparison

IT vs MDGL Comparison

Compare IT & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gartner Inc.

IT

Gartner Inc.

HOLD

Current Price

$133.24

Market Cap

9.8B

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$534.44

Market Cap

11.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IT
MDGL
Founded
1979
2011
Country
United States
United States
Employees
40
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.8B
11.1B
IPO Year
2010
2005

Fundamental Metrics

Financial Performance
Metric
IT
MDGL
Price
$133.24
$534.44
Analyst Decision
Hold
Strong Buy
Analyst Count
9
12
Target Price
$189.25
$674.45
AVG Volume (30 Days)
1.4M
308.2K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
41.32
EPS
3.18
N/A
Revenue
$2,021,441,000.00
$180,133,000.00
Revenue This Year
$3.52
$58.39
Revenue Next Year
$5.08
$48.55
P/E Ratio
$41.72
N/A
Revenue Growth
13.30
N/A
52 Week Low
$124.25
$286.75
52 Week High
$375.84
$615.00

Technical Indicators

Market Signals
Indicator
IT
MDGL
Relative Strength Index (RSI) 43.18 54.32
Support Level $124.25 $498.59
Resistance Level $162.80 $545.29
Average True Range (ATR) 5.21 22.69
MACD 0.83 3.86
Stochastic Oscillator 48.12 46.15

Price Performance

Historical Comparison
IT
MDGL

About IT Gartner Inc.

Gartner Inc delivers actionable, objective business and technology insights that drive smarter decisions and stronger performance on an organization's mission-critical priorities. It delivers its products and services globally through three reportable segments - Business and Technology Insights, Conferences and Consulting. Insights equips executives and their teams from every Majority function, geography, industry and sector with actionable, objective insights, guidance and tools. Conferences provides executives and teams across an organization the opportunity to learn, share and network. and Consulting serves senior executives technology-driven strategic initiatives leveraging the power of Gartner's actionable, objective insight. The Majority revenue is derived from the Insights segment.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: